We are live on
!
Find out more
Stoke Therapeutics
STOK
STOK
196 hedge funds and large institutions have $2.31B invested in Stoke Therapeutics in 2026 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 79 increasing their positions, 52 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
59% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 27
52% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 52
9% more capital invested
Capital invested by funds: $2.13B → $2.31B (+$189M)
7% more funds holding
Funds holding: 183 → 196 (+13)
2.94% more ownership
Funds ownership: 117.28% → 120.21% (+2.9%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
57% less call options, than puts
Call options by funds: $3.7M | Put options by funds: $8.68M
Holders
196
Holders Change
+13
Holders Change %
+7.1%
% of All Funds
2.41%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
43
Increased
79
Reduced
52
Closed
27
Calls
$3.7M
Puts
$8.68M
Net Calls
-$4.98M
Net Calls Change
-$22.7M
Top Buyers
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$38.8M |
| 2 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
-$21M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$10.5M |
| 4 |
Goldman Sachs
New York
|
-$10.2M |
| 5 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$8.26M |
